Lupin Shares in Spotlight: Acquisition of 3 Anti-Diabetes Trademarks Boosts Portfolio Strength!
The multinational pharmaceutical giant Lupin Limited has announced that it will expand its diabetes portfolio in the nation by acquiring the anti-diabetic trademarks GIBTULIO, GIBTULIO MET, and AJADUO from BoehringerIngelheim International GmbH. According to the agreement, Lupin will receive the trademark rights for these brands by March of the following year. In the Indian market, … Read more
